PODXL and cancer: In KPC (Pdx‐Cre; LSL‐KrasG12D+; LSL‐Trp53R172H/+) mice and orthotopic xenografts model, GC silencing and ITGB1 blockade both efficiently reduce cancer‐nerve interactions and mitigate PDAC progression.